Gainers

  • Unity Biotechnology UBX shares increased by 95.3% to $1.66 during Friday's pre-market session. The market value of their outstanding shares is at $114.8 million.
  • Rani Therapeutics Hldgs RANI stock moved upwards by 23.08% to $10.13. The company's market cap stands at $248.1 million. As per the press release, Q2 earnings came out 2 days ago.
  • Larimar Therapeutics LRMR stock rose 18.68% to $2.35. The company's market cap stands at $41.6 million. The company's, Q2 earnings came out yesterday.
  • LogicMark LGMK stock increased by 13.44% to $1.35. The company's market cap stands at $12.9 million. The company's, Q2 earnings came out yesterday.
  • Neoleukin Therapeutics NLTX shares increased by 12.74% to $1.15. The company's market cap stands at $48.9 million. As per the press release, Q2 earnings came out 3 days ago.
  • AirSculpt Technologies AIRS shares moved upwards by 12.61% to $10.0. The company's market cap stands at $556.4 million. As per the news, the Q2 earnings report came out today.

Losers

  • Aptinyx APTX shares fell 36.5% to $0.38 during Friday's pre-market session. The company's market cap stands at $25.8 million.
  • Co-Diagnostics CODX stock decreased by 30.79% to $4.47. The market value of their outstanding shares is at $151.0 million. The company's, Q2 earnings came out yesterday.
  • PLx Pharma PLXP stock fell 16.61% to $2.16. The company's market cap stands at $59.4 million. As per the news, the Q2 earnings report came out today.
  • Illumina ILMN shares decreased by 15.52% to $192.15. The market value of their outstanding shares is at $30.1 billion. As per the press release, Q2 earnings came out yesterday.
  • Certara CERT shares fell 14.62% to $17.24. The company's market cap stands at $2.7 billion. The company's, Q2 earnings came out 3 days ago.
  • AcelRx Pharmaceuticals ACRX shares declined by 12.9% to $0.27. The company's market cap stands at $40.0 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!